STOCK TITAN

Outset Medical to Present at Goldman Sachs 42nd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Outset Medical, Inc. (Nasdaq: OM), a medical technology innovator, announced its management's participation in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021, at 7:30am PT / 10:30am ET. The event will be available via live and archived webcast on Outset's investors page. Outset's flagship product, the Tablo Hemodialysis System, offers a groundbreaking solution to streamline dialysis delivery, ensuring it can be provided anywhere and anytime, significantly enhancing patient care and reducing costs.

Positive
  • None.
Negative
  • None.

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 7:30am PT / 10:30am ET.

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

FAQ

What date will Outset Medical participate in the Goldman Sachs Healthcare Conference?

Outset Medical will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on June 9, 2021.

What time is the Outset Medical fireside chat scheduled?

The fireside chat is scheduled for 7:30am PT / 10:30am ET.

Where can I watch the Outset Medical fireside chat?

The fireside chat will be available on the Investors section of Outset Medical's website.

What is the Tablo Hemodialysis System by Outset Medical?

The Tablo Hemodialysis System is a first-of-its-kind technology designed to simplify dialysis delivery and reduce costs.

What is the main goal of Outset Medical's technology?

Outset Medical aims to transform the dialysis experience for patients and providers by making it easier and more accessible.

Outset Medical, Inc.

NASDAQ:OM

OM Rankings

OM Latest News

OM Stock Data

39.46M
51.38M
2.13%
55.13%
6.37%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
SAN JOSE